Peel Hunt reiterated their buy rating on shares of Acal plc (LON:ACL) in a research report sent to investors on Monday, October 16th. They currently have a GBX 360 ($4.75) target price on the stock.
Several other brokerages have also weighed in on ACL. Numis Securities Ltd reaffirmed a buy rating and issued a GBX 370 ($4.88) target price on shares of Acal plc in a research report on Monday, October 16th. FinnCap reaffirmed a buy rating and issued a GBX 339 ($4.47) target price on shares of Acal plc in a research report on Monday, June 19th.
Acal plc (LON:ACL) opened at 321.125 on Monday. Acal plc has a 1-year low of GBX 203.20 and a 1-year high of GBX 342.55. The company has a 50 day moving average of GBX 310.08 and a 200 day moving average of GBX 291.97. The firm’s market capitalization is GBX 202.47 million.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/10/27/acal-plc-acl-rating-reiterated-by-peel-hunt.html.
About Acal plc
ACAL plc designs, manufactures and distributes electronic products and solutions. The Company operates through two segments: Custom Distribution and Design & Manufacturing. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.
Receive News & Ratings for Acal plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acal plc and related companies with MarketBeat.com's FREE daily email newsletter.